Home » Topics » BioWorld Science

BioWorld Science
RSS

Fujisawa, Nihon Shokubai claim CCK-B antagonists

May 24, 1996

ADIR claims melatonin receptor ligands for CNS disorders

May 24, 1996

Eagle Research to license Oral-Assist products

May 24, 1996

Orphan drug status for CEA-Scan

May 24, 1996

Peptide Therapeutics, Dr. Fooke to research arthritis diagnostics

May 24, 1996

Isis claims oligonucleotides for diagnostic use

May 24, 1996

Atrix completes phase III studies of Atridox

May 24, 1996

PolyHeme phase II results in trauma patients announced

May 24, 1996

RF-1051 receives orphan drug status in PWS

May 24, 1996

Amgen begins clinical testing of leptin

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 25, 2025.
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 24, 2025
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...